Acetylcholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, are used as part of the current treatment regimen but do not genuinely restore brain function in a clinical setting; instead, they just delay the advancement of AD. The gene discussed is ACHE; the disease is Alzheimer disease.